Impact of social determinants of health on treatment patterns and outcomes in metastatic non-small cell lung cancer [0.03%]
社会决定因素对转移性非小细胞肺癌治疗模式和结局的影响
Nathan R Hill,Amanda Crosbie,Rick Szymialis et al.
Nathan R Hill et al.
BackgroundThis study examined the association between social determinants of health (SDOH) and access to first-line therapy, time to treatment (TTT), and overall survival (OS) among patients with metastatic non-small cell lung cancer (mNSCL...
Assessment of alpelisib-induced hyperglycemia in a real-world setting: A nationwide claims data analysis [0.03%]
基于全国理赔数据的阿培利司诱发高血糖的真实世界评估分析
Mohamad Ismail,Jun Gong,Vincent D Marshall et al.
Mohamad Ismail et al.
IntroductionAlpelisib exhibits variability in length of drug exposure and clinical safety outside of clinical trials. This study aimed to bridge the gap between clinical trial outcomes and real-world evidence by quantifying the Time on Ther...
Tolerability and safety of extemporaneously prepared oral methotrexate suspension in pediatric acute lymphoblastic leukemia: Experience from a comprehensive cancer center in Jordan [0.03%]
约旦一家全面癌症中心儿科急性淋巴细胞白血病患儿甲氨蝶呤混悬剂的耐受性和安全性：经验分析
Manar Z Dirani,Mahmoud Rezeq,Batoul Zreigat et al.
Manar Z Dirani et al.
BackgroundAcute lymphoblastic leukemia (ALL) is the most common pediatric malignancy and requires prolonged maintenance chemotherapy. Methotrexate (MTX) is a core maintenance agent, typically given weekly for extended durations. In many set...
Infectious complications associated with tocilizumab following chimeric antigen receptor T-cell therapy [0.03%]
嵌合抗原受体T细胞治疗后托珠单抗相关的感染并发症
Virginia Bland,Daniel Przybylski
Virginia Bland
PurposeChimeric antigen receptor (CAR) T-cell therapy has reshaped the outlook for patients with relapsed or refractory hematologic malignancies. In pivotal trials, infections occurred in 19-56% and 42-69% of patients receiving CD19- and B-...
Author response In response to: JOPP-26-0271 The French Society for Oncology Pharmacy commentary on Iannopollo M., J Oncol Pharm Pract, 2026 [0.03%]
致编辑的信：对伊安诺波洛论文的评论回复
Mauro Iannopollo
Mauro Iannopollo
The French Society for Pharmacy Oncology's commentary on the article by Iannopollo M., published in April 2026 and titled "Rethinking centralised oncology pharmacy practice in the era of flat-dose immunotherapy, subcutaneous formulations and visit-administration day separation: A conceptual analysis and reform proposal" [0.03%]
法国药学肿瘤学会对Iannopollo M.于2026年4月发表的文章《反思免疫治疗、皮下制剂和访视给药日分离时代的集中化肿瘤药房实践：概念分析与改革建议》的评论
Florence Ranchon,Nicolas Cormier,Jean-Louis Cazin et al.
Florence Ranchon et al.
Stability studies of etoposide as syringes for intrathecal administration and syringes for pediatric oral administration [0.03%]
依托泊苷注射剂（用于脑脊髓给药）和口服混悬液稳定性研究
Jonathan Hua,Chloé Renon,Rachel Jaud et al.
Jonathan Hua et al.
IntroductionIn pediatric practice, etoposide is a cytotoxic drug that can be prescribed under various routes of administration according to the indication. These prescriptions can imply frequent preparations, which can be secured through ba...
Safety and efficacy of efbemalenograstim alfa for chemotherapy-induced neutropenia: A systematic review and meta-analysis of randomized controlled trials [0.03%]
艾非贝纳利珠单抗治疗化疗所致中性粒细胞减少症的有效性和安全性：系统评价和荟萃分析
Samiullah Shaikh,Waseem Nabi,Sidra Samad et al.
Samiullah Shaikh et al.
Chemotherapy-induced neutropenia (CIN) is a frequent and clinically significant complication of systemic cancer therapy, associated with increased infection risk, hospitalization, and treatment delays. Granulocyte colony-stimulating factors...
Real-World adherence and quality of life Among HER2-positive breast cancer patients receiving subcutaneous trastuzumab in Ghana: A pilot study [0.03%]
吉hana接受皮下曲妥珠单抗的her2阳性乳腺癌患者的现实依从性和生活质量：一项试点研究
Kofi Boamah Mensah,Adwoa Bemah Boamah Mensah,Darkwa Kakra Koampah et al.
Kofi Boamah Mensah et al.
BackgroundAdherence to trastuzumab is essential for achieving optimal outcomes in HER2-positive breast cancer; however, real-world data on adherence to subcutaneous formulations in low- and middle-income countries remain limited. This study...